ANAPTYSBIO CEO Daniel Faga's 2023 pay falls 69% to $7.5M
ANAPTYSBIO reports 2023 executive compensation
By ExecPay News
Published: April 24, 2024
ANAPTYSBIO reported fiscal year 2023 executive compensation information on April 24, 2024.
In 2023, three ANAPTYSBIO executives received on average a compensation package of $4.1M, a 62% decrease compared to previous year.
Average pay of disclosed executives at ANAPTYSBIO
Daniel Faga, Chief Executive Officer, received $7.5M in total, which decreased by 69% compared to 2022. 44% of Faga's compensation, or $3.3M, was in option awards. Faga also received $352K in non-equity incentive plan, $641K in salary, $1.7M in stock awards, as well as $1.5M in other compensation.
Paul Lizzul, Chief Medical Officer, received a compensation package of $2.4M, which decreased by 36% compared to previous year. 46% of the compensation package, or $1.1M, was in option awards.
Eric Loumeau, Chief Legal Officer, earned $2.3M in 2023, a 41% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2024.